<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03949738</url>
  </required_header>
  <id_info>
    <org_study_id>CAR ARDS</org_study_id>
    <nct_id>NCT03949738</nct_id>
  </id_info>
  <brief_title>Cerebrovascular Hemodynamics in Patients With ARDS.</brief_title>
  <official_title>Cerebrovascular Hemodynamics and Neurocognitive Outcome in Patients With Acute Respiratory Distress Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The acute respiratory distress syndrome (ARDS) is a life-threatening disease with functional
      impairment of the lung. It is characterized by an excessive inflammatory response of lung
      tissue, capillaries, and blood vessels and is associated with high mortality. Patients who
      survive the acute phase of this critical disease often suffer from long-term physical,
      psychological, and mental sequelae, as well as persistent cognitive deficits.

      In healthy individuals, autoregulatory mechanisms of the intracranial blood vessels keep
      blood supply to the brain independent of fluctuations in systemic blood pressure. In the case
      of a serious illness, these mechanisms of autoregulation may be impaired, which may favor
      cerebral hypoperfusion. Impairment of cerebrovascular hemodynamics can lead to neuronal
      damage in short and long term.

      The aim of this project is to investigate cerebrovascular autoregulation in adult patients
      with ARDS and to evaluate the cognitive outcome at 3, 6 and 12 months after discharge from
      the intensive care unit.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COx</measure>
    <time_frame>Assessment for 60 minutes per day during the acute phase of ARDS (maximum 14 days after ARDS onset).</time_frame>
    <description>Cerebral Oximetry Index (COx) as a moving correlation between arterial blood pressure and cerebral oximetry with a range from -1 to +1. A COx above 0.3 is defined as impaired cerebrovascular autoregulation. The minutes with COX above 0.3 will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Failures Questionnaire (CFQ)</measure>
    <time_frame>3, 6 and 12 months after discharge from ICU.</time_frame>
    <description>The Cognitive Failures Questionnaire is a self-report scale used to assess forgetfulness or inattention. It contains 25 items that are rated on a 5-point Likert scale, resulting in a total CFQ score varying from 0 to 100, with higher scores indicating more cognitive failures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Short Form (36) Health Survey (SF-36)</measure>
    <time_frame>3, 6 and 12 months after discharge from ICU.</time_frame>
    <description>The SF-36 is a questionnaire used to assess patient-reported health. It contains eight health-related topics. Each topic is rated on a scale from 0 to 100 with lower scores representing more disability.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">66</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>Adult patients with ARDS</arm_group_label>
    <description>Adults patients fulfilling the Berlin criteria for ARDS</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Near-infrared spectroscopy-based assessement of cerebral autoregulation.</intervention_name>
    <description>Cerebral autoregulation is assessed using a software that calculates correlation coefficients based on the values of cerebral oxygenation (detected by near-infrared spectroscopy) and invasively measured arterial blood pressure.
Correlation coefficients are calculated at 10-second intervals and averaged over a period of 300 seconds, resulting in an autoregulation index (cerebral oxygenation index, COx). The index can range between -1 and +1. It provides information about cerebral autoregulation capacity, with a value below 0.3 indicating intact cerebral autoregulation.</description>
    <arm_group_label>Adult patients with ARDS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the intensive care unit of the university hospital Hamburg-Eppendorf diagnosed
        with ARDS.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ARDS

        Exclusion Criteria:

          -  Pre-existing neurological diseases with known intracranial pathology

          -  Cerebrovascular disorders, including hemodynamically relevant extracranial vascular
             stenoses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universitätskrankenhaus Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Thompson BT, Chambers RC, Liu KD. Acute Respiratory Distress Syndrome. N Engl J Med. 2017 Aug 10;377(6):562-572. doi: 10.1056/NEJMra1608077. Review.</citation>
    <PMID>28792873</PMID>
  </reference>
  <reference>
    <citation>Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.</citation>
    <PMID>26903337</PMID>
  </reference>
  <reference>
    <citation>Brown SM, Wilson EL, Presson AP, Dinglas VD, Greene T, Hopkins RO, Needham DM; with the National Institutes of Health NHLBI ARDS Network. Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes. Thorax. 2017 Dec;72(12):1094-1103. doi: 10.1136/thoraxjnl-2017-210337. Epub 2017 Aug 4.</citation>
    <PMID>28778920</PMID>
  </reference>
  <reference>
    <citation>Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Jr. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2005 Feb 15;171(4):340-7. Epub 2004 Nov 12.</citation>
    <PMID>15542793</PMID>
  </reference>
  <reference>
    <citation>Schramm P, Closhen D, Felkel M, Berres M, Klein KU, David M, Werner C, Engelhard K. Influence of PEEP on cerebral blood flow and cerebrovascular autoregulation in patients with acute respiratory distress syndrome. J Neurosurg Anesthesiol. 2013 Apr;25(2):162-7. doi: 10.1097/ANA.0b013e31827c2f46.</citation>
    <PMID>23211642</PMID>
  </reference>
  <reference>
    <citation>LASSEN NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959 Apr;39(2):183-238.</citation>
    <PMID>13645234</PMID>
  </reference>
  <reference>
    <citation>Zweifel C, Dias C, Smielewski P, Czosnyka M. Continuous time-domain monitoring of cerebral autoregulation in neurocritical care. Med Eng Phys. 2014 May;36(5):638-45. doi: 10.1016/j.medengphy.2014.03.002. Epub 2014 Apr 1. Review.</citation>
    <PMID>24703503</PMID>
  </reference>
  <reference>
    <citation>Bullinger M. [Assessment of health related quality of life with the SF-36 Health Survey]. Rehabilitation (Stuttg). 1996 Aug;35(3):XVII-XXVII; quiz XXVII-XXIX. German.</citation>
    <PMID>8975342</PMID>
  </reference>
  <reference>
    <citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 Feb;21(1):1-16.</citation>
    <PMID>7126941</PMID>
  </reference>
  <reference>
    <citation>Murkin JM, Newman SP, Stump DA, Blumenthal JA. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995 May;59(5):1289-95.</citation>
    <PMID>7733754</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>June 14, 2020</last_update_submitted>
  <last_update_submitted_qc>June 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebral Autoregulation</keyword>
  <keyword>Cerebral Hemodynamics</keyword>
  <keyword>Cognitive Impairment</keyword>
  <keyword>Near-infrared Spectroscopy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

